Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-24-000135

Director acquired 5,967 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
FLATLEY JAY T Director 2024-05-31 Grant or award +5,967 10,183 D
Derivatives
FLATLEY JAY T Director 2024-05-31 Grant or award · Stock Option (right to buy) +17,901 17,901 D
Loading xslF345X05/wk-form4_1717540113.xml…